Navigation Links
European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™
Date:2/17/2012

SEATTLE, Feb. 17, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today that Pixuvri™ (pixantrone dimaleate) has been granted a positive opinion for conditional approval from the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"). Based on the CHMP's recommendation, CTI expects that a conditional marketing authorization for Pixuvri should be granted by the European Commission within the next few months. CHMP recommended Pixuvri for conditional approval as monotherapy for the treatment of adult patients with multiple relapsed or refractory aggressive non-Hodgkin B-cell lymphomas ("NHL").

If the CHMP's recommendation is formally adopted by the European Commission, Pixuvri would be approved for marketing in the 27 countries that are members of the E.U., as well as the European Economic Area.  The decision by the European Commission is typically issued approximately two to three months after the CHMP opinion and generally follows the recommendation from the CHMP. If the opinion is confirmed by the European Commission, Pixuvri would be the first drug approved for patients in this setting.  

"We are very pleased with the CHMP's positive recommendation recognizing the clinical benefit of Pixuvri in addressing a significant unmet medical need for patients with multiple relapsed or refractory aggressive B-cell NHL, and we believe that Pixuvri will add an important treatment option for physicians and provide a meaningful impact on patients," stated James A. Bianco, CEO of CTI.

"There are currently no proven effective therapies for these advanced NHL patients. Our goal for this late stage patient population is to control disease progression and symptoms as a cure is no longer an option. We are encouraged by the PFS noted in the PIX301 study and the opportunity this agent provides in treating this difficult to treat group of patients," said Bertrand
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology
2. Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings
3. European Pharmaceutical and Biotech Contract Manufacturing Markets
4. Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
5. ULURU Inc. Extends the European Altrazeal® License to Include the Middle East and Africa
6. Kinex Pharmaceuticals Acquires Rights for Technology and Products from Hanmi Pharmaceuticals, in United States and European Union Territories
7. BioMarin Receives Positive Opinion from European Regulatory Authorities for Expanded Biologics Manufacturing Facility
8. Dehaier Medical Enters European Homecare Medical Product Market
9. Successful ILM-Blue Patent Opposition Proceedings Before the European Patent Office; Patent Validity Confirmed
10. No European Scientists Left by 2020?
11. US and European Bariatric (Obesity) Surgical Devices Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... – Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Analysis Insulin Pumps ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... 8, 2011 As the economy recovery continues to ... competition and reduce health care costs. Running counter to ... that takes away employers, ability to save money by ... the Pharmaceutical Care Management Association (PCMA) said today. ...
... N.J., July 8, 2011 BD (Becton, Dickinson and Company) ... conduct a live webcast of its third fiscal quarter 2011 ... 9:00 a.m. (ET).  BD will issue a press release detailing ... of the conference call, along with related slides, will be ...
Cached Medicine Technology:As Economic Recovery Sputters, Independent Drugstores Shouldn't Shoulder Employers With Higher Costs 2
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... the potential to ward off depression among retirees, particularly ... online in The Journals of Gerontology, Series ... the article " Internet Use and Depression Among Retired ... ," the authors report that Internet use reduced the ... their study sample. , Late-life depression affects between ...
(Date:4/17/2014)... Council scientists and their partners have found that their ... the transmission of multiple sexually transmitted infections (STIs) in ... simplex virus 2 (HSV-2), and human papillomavirus (HPV). The ... gel is effective against multiple strains of HIV, and ... all three viruses of at least eight hours prior ...
(Date:4/17/2014)... 2014 Meaningful long-term survival is possible for ... abdomen when treated with cytoreductive surgery with Hyperthermic ... analysis by physicians at Wake Forest Baptist Medical ... reported, single-center experience with cytoreductive surgery and HIPEC, ... analysis of 20 years, worth of patient data ...
Breaking Medicine News(10 mins):Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... as U.S. regulators scrutinize safety of products linked to dozens ... drug makers announced a voluntary withdrawal Thursday of oral cough ... move affects only "infant" oral medicines, not those intended and ... it comes as U.S. regulators review the products, safety, following ...
... UNION CITY, Calif., Oct. 11 Abaxis, Inc.,(Nasdaq: ... systems, has scheduled a conference call to discuss its,financial ... ended,September 30, 2007. The call will be at 4:15 ... (877) 356-5706 or (706) 643-0580 to access the,conference call, ...
... University of North Dakota and Valeant Pharmaceuticals join ... workplace wellness leadership effort, ... University of North Dakota and Valeant,Pharmaceuticals, were accredited with the ... their employees and their,families by agreeing to meet an exceptionally ...
... Yahoo! Answers -, NEW YORK, Oct. 11 ... Frost, star of the reality show,Supernanny, which reaches parents ... new cause-marketing initiative, Time To,Talk(TM) (http://www.TimeToTalk.org ) by ... Yahoo! Answers, Yahoo! visitors from around the world share,information ...
... Israel and SAN RAMON, California, October 11 ... of the UltraShape,Contour I, the first clinically ... will be presented at the American Society ... 2007 in Chicago,Illinois. The presentation is entitled ...
... health benefits. Researchers at the University of Missouri-Columbia have ... common food-borne diseases. , Researchers Azlin Mustapha, associate professor ... and Natural Resources, and Atreyee Das, a doctoral student ... examining the inhibitory effects of numerous types of red ...
Cached Medicine News:Health News:Drug Makers Withdraw Cough, Cold Meds for Infants 2Health News:Drug Makers Withdraw Cough, Cold Meds for Infants 3Health News:Abaxis to Report Second Quarter Fiscal 2008 Financial Results Wednesday, October 24, 2007 2Health News:Three Organizations Receive CEO Cancer Gold Standard(TM) Accreditation 2Health News:Three Organizations Receive CEO Cancer Gold Standard(TM) Accreditation 3Health News:'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM) 2Health News:'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM) 3Health News:UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting 2Health News:UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting 3Health News:Red wine and grape juice help defend against food-borne diseases, according to MU researchers 2
... Revision Knee System features ... femoral replacement options. The centerpiece ... Rotating Hinge Knee, promotes the ... and is designed for distribution ...
The Advance stemmed medial-pivot knee is a revision knee that provides unique and competitive features....
... LCCK Femoral Component is intended for ... due to inadequate mediolateral, anteroposterior and ... and/or stem extensions due to inadequate ... available with a non-coated fixation surface. ...
The Duracon system provides superb articular conformity throughout the range of motion, reducing contact stresses generally associated with wear....
Medicine Products: